Cite
B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit
MLA
Sarah Bajorek, et al. “B. Infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit.” Frontiers in Pediatrics, vol. 9, Jan. 2022. EBSCOhost, https://doi.org/10.3389/fped.2021.795970.
APA
Sarah Bajorek, Rebbeca M. Duar, Maxwell Corrigan, Christa Matrone, Kathryn A. Winn, Susan Norman, Ryan D. Mitchell, Orla Cagney, Alexander A. Aksenov, Alexey V. Melnik, Evguenia Kopylova, & Jose Perez. (2022). B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit. Frontiers in Pediatrics, 9. https://doi.org/10.3389/fped.2021.795970
Chicago
Sarah Bajorek, Rebbeca M. Duar, Maxwell Corrigan, Christa Matrone, Kathryn A. Winn, Susan Norman, Ryan D. Mitchell, et al. 2022. “B. Infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit.” Frontiers in Pediatrics 9 (January). doi:10.3389/fped.2021.795970.